Pharmaceutical Intermediates
- • Analgesics (57)
- • Anesthetics (52)
- • Anti-Addiction Agents (8)
- • Antibacterials (117)
- • Anticonvulsants (20)
- • Antidementia Agents (23)
- • Antidepressants (35)
- • Antiemetics (24)
- • Antifungals (24)
- • Antigout Agents (9)
- • Anti-inflammatory Agents (28)
- • Antimigraine Agents (21)
- • Antineoplastics (427)
- • Antiparasitics (11)
- • Antiparkinson Agents (28)
- • Antipsychotics (54)
- • Antispasticity Agents (12)
- • Antivirals (146)
- • Anxiolytics (16)
- • Blood Glucose Regulators (105)
- • Blood Products (61)
- • Cardiovascular Agents (179)
- • CNS Agents (22)
- • Dental and Oral Agents (8)
- • Dermatological Agents (19)
- • Electrolytes (15)
- • Gastrointestinal Agents (62)
- • Genetic/Enzyme Disorder (12)
- • Genitourinary Agents (47)
- • Immunological Agents (36)
- • Metabolic Bone Disease (6)
- • Ophthalmic Agents (343)
- • Respiratory Tract (51)
- • Skeletal Muscle Relaxants (5)
- • Sleep Disorder Agents (28)
- • Oled Material Intermediate (333)
- • Heterocyclic Compound (9764)
- • Bulk Drug Intermediates (17728)
Related News
-
India Imposes Final Anti‑Dumping Duties on Ethylenediamine from China, EU, Saudi Arabia, and Taiwan, China, with Top Rate of $575/tonne
2026-06-30 -
US Chemical Shutdown Wave Expands, PS Units Become the Hardest Hit Segment
2026-06-30 -
Haldia Petrochemicals Pipeline Fire in India Adds Uncertainty to Asia's Naphtha Market
2026-07-03 -
关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances
2026-06-26 -
BASF's Intensified Moves from May to June: Plant Closures, Divestitures, and Transformation in Sync
2026-06-26 -
Semcorp's Hungarian Factory Ordered to Shut Down Over Pollution
2026-07-08
Antimigraine Agents
Phenyl vinyl sulfone
(5535-48-8)-
pharmaceutical grade / 98%
$100/KG EXW
-
- / 99.00%
-
industrial Grade / 98%
-
Industrial Grade / 99%
Request for quotation , get quotes from more suppliers.
-
Pharmaceutical Grade / 95%
-
Industrial Grade,Pharma Grade / 99%
-
Industrial Grade / pharmaceutical grade / 99%
-
- / 99.00%
Request for quotation , get quotes from more suppliers.
Frequently Asked Questions
Antimigraine agents are medications specifically designed to treat or prevent migraine headaches. These drugs work by targeting the underlying mechanisms of migraines, such as vasoconstriction of blood vessels, modulation of neurotransmitters like serotonin, or inhibition of inflammatory pathways. Common classes include triptans, ergot alkaloids, CGRP antagonists, and preventive agents like beta-blockers or anticonvulsants.
Triptans are a widely used class of antimigraine agents that act as selective serotonin (5-HT1B/1D) receptor agonists. They help relieve migraine symptoms by constricting dilated cranial blood vessels and inhibiting the release of pro-inflammatory neuropeptides. Triptans are most effective when taken early in a migraine attack and are available in various formulations including oral tablets, nasal sprays, and injections.
Side effects of antimigraine agents vary by drug class. Triptans may cause dizziness, fatigue, tingling sensations, or chest tightness. Ergot derivatives can lead to nausea or peripheral vasoconstriction. Newer CGRP inhibitors are generally well-tolerated but may cause injection site reactions or constipation. Preventive medications like beta-blockers might result in bradycardia or fatigue. Always consult a healthcare provider before starting any antimigraine therapy.
Selecting the appropriate antimigraine agent depends on several factors:1. Migraine frequency and severity.2. Patient’s medical history and contraindications (e.g., cardiovascular conditions may limit triptan use).3. Response to previous treatments.4. Need for acute relief versus long-term prevention.5. Drug formulation preferences (oral, nasal, injectable).A neurologist or headache specialist can help tailor therapy based on individual patient profiles.
Yes, several non-pharmacological approaches can complement or sometimes replace antimigraine agents, especially for patients with contraindications or medication overuse concerns. These include cognitive behavioral therapy (CBT), biofeedback, acupuncture, regular aerobic exercise, and lifestyle modifications like maintaining consistent sleep schedules and identifying dietary triggers. Devices such as transcranial magnetic stimulation (TMS) or vagus nerve stimulators are also FDA-approved for migraine management.